About this trial
The researchers are evaluating mechanisms of uterine fluid absorption during early pregnancy
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Subject must be a healthy woman between the ages of 18 and 45 years.
Women with diagnosed endometriosis or infertility (cases).
Women without a diagnosis of endometriosis or infertility (controls).
Subject must have regular menstrual cycles.
Disqualifiers
Pregnant women.
Study subjects with endometrial cancer.
Study subjects with a history of endometrial ablation.
Study subjects with undiagnosed uterine bleeding.
Trial population
Women between the ages of 18-45 with or without endometriosis.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Expression levels of selected ion channels in human endometrium biopsies across the menstrual cycle.
Immunolocalization of ion channel levels ENaCα, SLC5A1 and SLC5A3 in endometrial tissues.
Secondary outcomes
Compare relative protein expression of ENaCα, SLC5A1 and SLC5A3 by immunohistochemistry
Compare relative protein expression of ENaCα, SLC5A1 and SLC5A3 by immunohistochemistry in the human endometrial biopsies from women with or without endometriosis.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Johns Hopkins University
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
National Institutes of Health (NIH)
Collaborator